Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC — Form D
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC of CLAYMONT, DE, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-08-09. The offering totals $87K, of which $87K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-08-09
- Form: D
- Accession: 0001989138-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $87K
- Amount sold: $87K
- Investors: 3
- Date of first sale: 2023-07-28
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-489211
Issuer
- Name: Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC
- CIK: 0001989138
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2093 PHILADELPHIA PIKE, CLAYMONT, DE, 19703
- Phone: (360) 946-0604
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| LLC Sydecar | Director | Claymont, DE |
| Taylor Hughes | Executive Officer | Claymont, DE |
More